tiprankstipranks
Prescient Therapeutics Limited (AU:PTX)
:PTX
Australian Market

Prescient Therapeutics Limited (PTX) Financial Statements

Compare
10 Followers

Prescient Therapeutics Limited Financial Overview

Prescient Therapeutics Limited's market cap is currently AU$39.46M. The company's EPS TTM is AU$-0.01; its P/E ratio is ―; Prescient Therapeutics Limited is scheduled to report earnings on February 21, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19MAU$ 1.03M
Gross ProfitAU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19MAU$ 1.03M
Operating IncomeAU$ -7.19MAU$ -9.89MAU$ -7.10MAU$ -5.43MAU$ -4.49M
EBITDAAU$ -7.19MAU$ -7.46MAU$ -5.21MAU$ -4.24MAU$ -3.46M
Net IncomeAU$ -8.24MAU$ -7.00MAU$ -5.12MAU$ -4.15MAU$ -3.32M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 14.51MAU$ 21.92MAU$ 12.28MAU$ 16.12MAU$ 7.38M
Total AssetsAU$ 20.39MAU$ 28.11MAU$ 17.62MAU$ 20.97MAU$ 12.07M
Total DebtAU$ 330.49KAU$ 0.00AU$ 0.00AU$ 165.83KAU$ 156.88K
Net DebtAU$ -10.16MAU$ -5.90MAU$ -12.26MAU$ -15.93MAU$ -7.20M
Total LiabilitiesAU$ 2.33MAU$ 2.03MAU$ 856.01KAU$ 539.68KAU$ 883.95K
Stockholders' EquityAU$ 18.07MAU$ 26.08MAU$ 16.76MAU$ 20.43MAU$ 11.19M
Cash Flow
Free Cash FlowAU$ -7.40MAU$ -6.19MAU$ -4.32MAU$ -3.97MAU$ -2.32M
Operating Cash FlowAU$ -7.40MAU$ -6.19MAU$ -4.31MAU$ -3.97MAU$ -2.32M
Investing Cash FlowAU$ 12.00MAU$ -16.00MAU$ -4.43KAU$ -2.31KAU$ 0.00
Financing Cash FlowAU$ 18.15KAU$ 15.83MAU$ 428.29KAU$ 12.75MAU$ 0.00
Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History

Prescient Therapeutics Limited Debt to Assets

Prescient Therapeutics Limited Cash Flow

Prescient Therapeutics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis